Definitive Healthcare’s (DH) “Hold” Rating Reaffirmed at Needham & Company LLC

Needham & Company LLC reaffirmed their hold rating on shares of Definitive Healthcare (NASDAQ:DH) in a research note released on Friday,Benzinga reports.

Other equities analysts have also issued reports about the company. Robert W. Baird reduced their price target on Definitive Healthcare from $6.00 to $5.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 7th. Stifel Nicolaus reduced their price target on Definitive Healthcare from $9.50 to $7.50 and set a “buy” rating on the stock in a research report on Wednesday, July 31st. BTIG Research assumed coverage on Definitive Healthcare in a research report on Tuesday, September 17th. They set a “buy” rating and a $7.00 price target on the stock. Deutsche Bank Aktiengesellschaft cut their price objective on Definitive Healthcare from $7.00 to $5.00 and set a “hold” rating on the stock in a research report on Friday, August 9th. Finally, JPMorgan Chase & Co. lowered Definitive Healthcare from a “neutral” rating to an “underweight” rating and cut their price objective for the stock from $7.00 to $5.00 in a research report on Wednesday, July 31st. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $5.81.

Definitive Healthcare Price Performance

DH traded down $0.07 on Friday, hitting $4.24. 1,200,343 shares of the company were exchanged, compared to its average volume of 326,752. The firm has a fifty day simple moving average of $4.36 and a two-hundred day simple moving average of $5.01. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.40 and a quick ratio of 2.40. Definitive Healthcare has a 12 month low of $3.19 and a 12 month high of $10.62.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the stock. Norden Group LLC purchased a new position in Definitive Healthcare during the first quarter valued at $83,000. Intech Investment Management LLC purchased a new position in shares of Definitive Healthcare in the third quarter worth $55,000. Susquehanna Fundamental Investments LLC purchased a new position in shares of Definitive Healthcare in the first quarter worth $120,000. Sanctuary Advisors LLC purchased a new position in shares of Definitive Healthcare in the second quarter worth $85,000. Finally, Bleakley Financial Group LLC purchased a new position in shares of Definitive Healthcare in the third quarter worth $74,000. Hedge funds and other institutional investors own 98.67% of the company’s stock.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.